🔎 Trials Near Me

Home › Macular Edema › Florida

Macular Edema clinical trials in Florida

5 studies for Macular Edema are looking for participants at sites in Florida.

Cities in Florida

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

  • Retina Vitreous Associates of Florida ( Site 0034), Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07705555

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  • Retina Group of Florida - Fort Lauderdale Retina Center, Fort Lauderdale
  • Florida Retina Institute, Jacksonville Southside, Jacksonville
  • Advanced Research Institute, Pompano Beach
  • and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06962839

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

  • Center for Retina and Macular Disease ( Site 0047), Winter Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07705607

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

  • Florida Eye Clinic, Altamonte Springs
  • Retina Group of Florida (Ft. Lauderdale), Fort Lauderdale
  • Retina Vitreous Associates of Florida (St. Petersburg), St. Petersburg
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06990399

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

  • Florida Eye Clinic, Altamonte Springs
  • Retina Group of Florida (Ft. Lauderdale), Fort Lauderdale
  • Retina Vitreous Associates of Florida (St. Petersburg), St. Petersburg
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06996080

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.